Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7505048rdf:typepubmed:Citationlld:pubmed
pubmed-article:7505048lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:7505048lifeskim:mentionsumls-concept:C0332208lld:lifeskim
pubmed-article:7505048lifeskim:mentionsumls-concept:C1457869lld:lifeskim
pubmed-article:7505048pubmed:issue2lld:pubmed
pubmed-article:7505048pubmed:dateCreated1994-1-19lld:pubmed
pubmed-article:7505048pubmed:abstractTextWe describe 2 cases of proximal tubular defects induced by the administration of ifosfamide at a dosage of 6 g/m2/course over 2 days in children with a diagnosis of malignant mesenchymal tumors. This adverse effect could be minimized dividing dosage of the drug. However at present it is not clear if divided doses are completely safe.lld:pubmed
pubmed-article:7505048pubmed:languageenglld:pubmed
pubmed-article:7505048pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:citationSubsetIMlld:pubmed
pubmed-article:7505048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7505048pubmed:statusMEDLINElld:pubmed
pubmed-article:7505048pubmed:issn0098-1532lld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:MeleroCClld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:MulecHHlld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:VivancoJ LJLlld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:López PérezJJlld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:VaraJJlld:pubmed
pubmed-article:7505048pubmed:authorpubmed-author:Torres...lld:pubmed
pubmed-article:7505048pubmed:issnTypePrintlld:pubmed
pubmed-article:7505048pubmed:volume22lld:pubmed
pubmed-article:7505048pubmed:ownerNLMlld:pubmed
pubmed-article:7505048pubmed:authorsCompleteYlld:pubmed
pubmed-article:7505048pubmed:pagination144-6lld:pubmed
pubmed-article:7505048pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:meshHeadingpubmed-meshheading:7505048-...lld:pubmed
pubmed-article:7505048pubmed:year1994lld:pubmed
pubmed-article:7505048pubmed:articleTitleIfosfamide-induced renal tubular defect.lld:pubmed
pubmed-article:7505048pubmed:affiliationDepartment of Pediatric Hematology-Oncology, Social Security Hospital 12 de Octubre, Madrid, Spain.lld:pubmed
pubmed-article:7505048pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7505048pubmed:publicationTypeCase Reportslld:pubmed